Search

This study aims to examine if history or presence of endometriomas is an independent risk factor for adhesive disease, longer operative time, and higher blood loss in patients undergoing endometriosis surgery. Our study was a retrospective chart review which reviewed the endometriosis cases of two surgeons at our institution from March 2018 to March 2021. A report was generated using CPT codes billed for the surgeries performed. 11 CPT codes were used to ensure we captured all endometriosis cases. These codes included any procedure of the ovary, fallopian tube, excision of endometriosis, or laparoscopic appendectomy. Charts were then reviewed and included in the study if endometriosis was confirmed on pathology. Comparisons were made using Wilcoxon rank sum and Chi-Squared tests. N/A. N/A. N/A. The query resulted in 3,106 matches for the 2 surgeons using the 11 CPT codes queried with 1,120 individual surgical cases. Of these patients, 389 had endometriosis confirmed on pathology and were included in the analysis. We analyzed three outcome variables at time of surgery including presence of adhesions, case length, and blood loss in the setting of one risk factor, prior surgical or image history of endometrioma. There was a higher percentage of patients with a prior surgical or image history of endometrioma also having adhesions (76.47%), compared to those who did not (45.52%) (p<0.001). The median case length (372 min vs 221 min) and median blood loss (50cc vs 25cc) were both statistically significantly higher amongst patients with prior surgical or image history of endometrioma compared to those who did not. Of patients undergoing surgery for endometriosis, those with endometriomas or a history of endometriomas had a higher rate of adhesions, longer case length, and greater blood loss compared to those who did not. This information will help improve surgical preparation, expectations, and counseling. [ABSTRACT FROM AUTHOR]

This paper provides an overview of issues in the integration of genetic (related to hereditary DNA) and genomic (related to genes and their functions) information in cancer care for individuals and families who are part of health care systems worldwide, from low to high resourced. National and regional cancer plans have the potential to integrate genetic and genomic information with a goal of identifying and helping individuals and families with and at risk of cancer. Healthcare professionals and the public have the opportunity to increase their genetic literacy and communication about cancer family history to enhance cancer control, prevention, and tailored therapies. [ABSTRACT FROM PUBLISHER]